Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use

American Heart Journal

Volumn 162, Issue 1, 2011, Pages

  Voora, Deepak ^a   Horton, John ^a   Shah, Svati H ^a   Shaw, Linda K ^a   Newby, L Kristin ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

A2AR GENE; ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG USE; F2R GENE; FEMALE; FOLLOW UP; GENE; GENETIC DATABASE; GENETIC RESISTANCE; GNB3 GENE; GP1BA GENE; GPVI GENE; HETEROZYGOTE; HUMAN; IN VITRO STUDY; ITGA2 GENE; ITGB3 GENE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEAR1 GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTGS1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THBS1 GENE; VAV3 GENE;

EID: 79960175185     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.03.026     Document Type: Article

References (30)

1. Antithrombotic Trialists Collaboration Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials The Lancet 373 2009 1849 1860
2. T. Cuisset, C. Frere, and J. Quilici Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting Am Heart J 157 2009 889 893
3. A.L. Frelinger III, M.I. Furman, and M.D. Linden Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance Circulation 113 2006 2888 2896 (Pubitemid 44297229)
4. A.L. Frelinger III, Y. Li, and M.D. Linden Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization Circulation 120 2009 2586 2596
5. N. Faraday, L.R. Yanek, and R. Mathias Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1 Circulation 115 2007 2490 2496 (Pubitemid 46763222)
6. N. Clappers, M.G. van Oijen, and S. Sundaresan The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid Thromb Haemost 100 2008 70 75 (Pubitemid 351948747)
7. G. Syros, R. Mehran, and G. Weisz Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention Acute Card Care 11 2009 88 91
8. A. Cervera, D. Tassies, and V. Obach The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy Cerebrovasc Dis 24 2007 242 246 (Pubitemid 47295591)
9. A. Lepantalo, J. Mikkelsson, and J.C. Resendiz Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients Thromb Haemost 95 2006 253 259
10. A. Undas, K. Brummel, and J. Musial PlA2 polymorphism of {beta}3 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury Circulation 104 2001 2666 2672 (Pubitemid 33108131)
11. S.M. Smith, H.M. Judge, and G. Peters PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy Platelets 16 2005 340 345 (Pubitemid 41491703)
12. H. Douglas, K. Michaelides, and D.A. Gorog Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis Heart 87 2002 70 74 (Pubitemid 34074959)
13. J.E. Herrera, R. Qayyum, and N. Faraday Platelet response to aspirin is under polygenic control of variants in the VAV3 and phospholipase C gamma 2 (PLCG2) genes Circulation 118 2008 S326 [Abstract]
14. J.E. Herrera-Galeano, D.M. Becker, and A.F. Wilson A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability Arterioscler Thromb Vasc Biol 28 2008 1484 1490
15. N.V. Narizhneva, V.J. Byers-Ward, and M.J. Quinn Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction J Biol Chem 279 2004 21651 21657 (Pubitemid 38656577)
16. T.J. Kunicki, S.A. Williams, and D.R. Salomon Genetics of platelet reactivity in normal, healthy individuals J Thromb Haemost 7 2009 2116 2122
17. D.L. Yee, A.L. Bergeron, and C.W. Sun Platelet hyperreactivity generalizes to multiple forms of stimulation J Thromb Haemost 4 2006 2043 2050 (Pubitemid 44226787)
18. K. Freeman, S. Farrow, and A. Schmaier Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans Am J Hypertens 8 1995 863 869
19. A. Helgadottir, G. Thorleifsson, and A. Manolescu A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493 (Pubitemid 46906618)
20. S.H. Shah, E.R. Hauser, and D. Crosslin ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention Atherosclerosis 201 2008 148 154
21. E. Ollikainen, J. Mikkelsson, and M. Perola Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men Atherosclerosis 176 2004 95 99 (Pubitemid 39078650)
22. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/ gxe, 2006.
23. F.G.R. Fowkes, J.F. Price, and M.C.W. Stewart Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JAMA 303 2010 841 848
24. D.L. Bhatt, M.D. Flather, and W. Hacke Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial J Am Coll Cardiol 49 2007 1982 1988 (Pubitemid 46694290)
25. C.R. Lee, K.E. North, and M.S. Bray Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study Clin Pharmacol Ther 83 2008 52 60
26. C. Le Hello, R. Morello, and A. Lequerrec Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting Thromb J 5 2007 19 25
27. E.J. Topol, J. McCarthy, and S. Gabriel Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction Circulation 104 2001 2641 2644 (Pubitemid 33108126)
28. M. Matarin, W.M. Brown, and J.A. Hardy Association of integrin [alpha]2 gene variants with ischemic stroke J Cereb Blood Flow Metab 28 2007 81 89
29. D. Kenny, C. Muckian, and D.J. Fitzgerald Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients J Thromb Thrombolysis 13 2002 13 19 (Pubitemid 34624810)
30. N.P. Paynter, D.I. Chasman, and G. Pare Association between a literature-based genetic risk score and cardiovascular events in women JAMA 303 2010 631 637